Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Dopamine D2 Receptor Blocking Peptide (AC1218)
Cat.#: ACPP-1218
Specifications
Despition Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1252 Robo3 Blocking Peptide (AC1252) 250 µg inquiry ACPP-1019 Recombinant Human GPRC5A Protein (Fc Tag) (AC1019) 50 µg inquiry ACPP-1647 Human TUBB3 Protein (AC1647) 2 µg inquiry ACPP-1575 Human HMOX1 Protein (AC1575) 10 µg inquiry ACPP-1716 Mouse ANGPTL7 Protein (AC1716) 1 µg inquiry ACPP-1773 Human LIN28 Protein (AC1773) 2 µg inquiry ACPP-1573 Human YWHAG Protein, His (AC1573) 2 µg inquiry ACPP-1766 Human HMGA2 Protein (AC1766) 2 µg inquiry ACPP-1214 Ki67 Blocking Peptide (AC1214) 250 µg inquiry ACPP-1280 SRPX2 Blocking Peptide (AC1280) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket